New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
08:17 EDTSPASparton to manufacture PathoGenetix RESOLUTION microbial genotyping system
Sparton has been chosen by PathoGenetix as the design and manufacturing partner for their RESOLUTION microbial genotyping system. PathoGenetix is a developer of an automated system for rapid bacterial strain typing. Under the terms of the agreement, Sparton will conduct design for manufacture and pilot production of a limited number of pre-commercial instruments for the RESOLUTION System, which is slated for commercial availability in late 2014. Pre-commercial units of the RESOLUTION System are currently undergoing testing and evaluation by government and food industry partners.
News For SPA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 9, 2014
09:43 EDTSPASparton upgraded to Outperform from Market Perform at Barrington
Barrington upgraded Sparton to Outperform with a $31 price target saying the company's new five]year plan should drive share appreciation.
09:40 EDTSPASparton upgraded to Outperform from Market Perform at Barrington
Subscribe for More Information
October 8, 2014
08:48 EDTSPASparton to host investor day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use